Anderson Hoagland & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67M Buy
29,017
+50
+0.2% +$6.59K 0.29% 78
2026
Q1
$4.04M Hold
28,967
0.35% 72
2025
Q4
$3.56M Buy
+28,967
New +$3.52M 0.31% 78
2020
Q1
Sell
-11,420
Closed -$768K 81
2019
Q4
$768K Hold
11,420
0.43% 69
2019
Q3
$726K Hold
11,420
0.44% 66
2019
Q2
$711K Sell
11,420
-16,120
-59% -$1.06M 0.44% 64
2019
Q1
$1.81M Hold
27,540
1.09% 27
2018
Q4
$1.77M Hold
27,540
1.26% 21
2018
Q3
$2.16M Hold
27,540
1.21% 23
2018
Q2
$1.95M Hold
27,540
1.09% 28
2018
Q1
$2.08M Sell
27,540
-4,075
-13% -$324K 1.19% 23
2017
Q4
$2.27M Hold
31,615
1.33% 21
2017
Q3
$2.56M Hold
31,615
1.58% 16
2017
Q2
$2.24M Hold
31,615
1.43% 19
2017
Q1
$2.15M Hold
31,615
1.16% 28
2016
Q4
$2.26M Hold
31,615
1.32% 23
2016
Q3
$2.5M Hold
31,615
1.44% 22
2016
Q2
$2.64M Hold
31,615
1.62% 18
2016
Q1
$2.9M Buy
31,615
+5,000
+19% +$451K 1.8% 22
2015
Q4
$2.69M Hold
26,615
1.66% 26
2015
Q3
$2.61M Hold
26,615
1.66% 28
2015
Q2
$3.12M Hold
26,615
1.81% 22
2015
Q1
$2.67M Hold
26,615
1.55% 29
2014
Q4
$2.51M Hold
26,615
1.52% 32
2014
Q3
$2.86M Hold
26,615
1.77% 25
2014
Q2
$2.21M Buy
26,615
+5,160
+24% +$402K 1.42% 31
2014
Q1
$1.52M Buy
21,455
+5,050
+31% +$396K 1.01% 37
2013
Q4
$1.23M Hold
16,405
0.85% 37
2013
Q3
$1.03M Buy
+16,405
New +$980K 0.71% 42

Other funds holding GILD

Anderson Hoagland & Co's GILD Position: Q2 2026 in Review

Anderson Hoagland & Co increased its Gilead Sciences (GILD) stake by 0.17% in Q2 2026, buying an estimated $6.59K and bringing the position to 29,017 shares worth $3.67M. The position accounts for 0.29% of the portfolio, ranked #78.

Anderson Hoagland & Co first reported a position in GILD in Q3 2013 and has held it in 29 quarters since. The position peaked at $4.04M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Anderson Hoagland & Co held 29,017 shares of Gilead Sciences worth $3.67M as of Q2 2026.
  • Anderson Hoagland & Co bought 50 Gilead Sciences shares in Q2 2026, an estimated $6.59K.
  • Gilead Sciences made up 0.29% of Anderson Hoagland & Co's portfolio in Q2 2026, its #78 holding.
  • Anderson Hoagland & Co first reported a position in Gilead Sciences in Q3 2013 and has held it in 29 quarters since.
  • Anderson Hoagland & Co's Gilead Sciences position peaked at $4.04M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.